FDA grants priority review to TAR-200, which demonstrated an 82% complete response in high-risk bladder cancer unresponsive ...

Raritan, New Jersey Friday, July 18, 2025, 15:00 Hrs [IST] ...

Based on durable response data, TAR-200 has been given priority review for the treatment of patients with high-risk ...

RNA bundled in lipid nanoparticles trains T cells in mice to eliminate cancer. Coupled with noninvasive imaging, researchers tracked the in situ CAR-T cells to assess their effectiveness and safety.

The Food and Drug Administration (FDA) has granted Priority Review to TAR-200 for the treatment of patients with Bacillus Calmette-Guérin (BCG)-unresponsive high-risk non-muscle invasive bladder ...

The New Brunswick, N.J., pharmaceutical giant on Thursday said the application covers TAR-200 for the treatment of patients with Bacillus Calmette-Guerin-unresponsive high-risk non-muscle invasive ...

Satellite cells are muscle stem cells responsible for muscle growth and regeneration in the postnatal stages. While these cells could significantly improve the success rates of experimental cell ...

IN a recent letter1 we described the prediction and discovery by X-rays of an – intramolecular transformation on stretching myosin, and pointed out the close analogy in molecular configuration ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) granted Priority Review to the ...